Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02326311
Title Optimization of TKIs Treatment and Quality of Life in Ph+ CML Patients >=60 Years in Deep Molecular Response
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Indications

chronic myeloid leukemia

Therapies

Dasatinib

Nilotinib

Imatinib

Age Groups: adult | senior
Covered Countries ITA


No variant requirements are available.